Dengue: a continuing global threat
Open accessThe DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Until recent advances in vaccine development [16–17], and the approval and potential availability of the first product in 2016 [18], dengue has been unique among the major vector-borne diseases, in that prevention from infection could only be attempted by reducing or eliminating bites by infected vector mosquitoes [19, 20].”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although a vaccine could be available as early as 2016, vector control remains the primary approach used to prevent dengue, the most common and widespread arbovirus of humans worldwide.”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Self-citationLanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,818 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodSelf-citationDengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632 · cited 1×
“One advantage of this assay is the ability to determine viral titre early in dengue illness, which is believed to be an important predictor of disease severity 102 .”
BackgroundGuzmán, M. G., & Kouri, G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00171-2 · Cited by 1,163
Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers
Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenburg, F., Keystone, J. S., Pandey, P., & Cetron, M. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051331 · Cited by 1,081
Dengue and dengue haemorrhagic fever
Rigau-Pérez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., & Vance Vorndam, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12483-7 · Cited by 1,051
Self-citationCross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943 · cited 1×
“The available data suggest that neutralizing antibodies are the major contributors to protective immunity 124,125 , however the role of the cellular immune response requires further study 123 .”
BackgroundCalisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893 · cited 1×
“These tests are mainly for research and vaccine studies 90–94 .”
BackgroundOriginal antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821 · cited 1×
“…CD4 + and CD8 + cells that have a diminished capacity to kill but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and…”
BackgroundDengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804 · cited 5×
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 3
- Vorndam, V. & Kuno, G. In Dengue and Dengue Hemorrhagic Fever (eds Gubler, D. J. & Kuno, G.) 313–333 (CAB International, New York, USA, 1997).
- Gubler, D. J. Serologic diagnosis of dengue/dengue haemorrhagic fever. Dengue Bull. 20, 20–23 (1996).
- Singh, K. R. P. & Paul, S. D. Multiplication of arboviruses in cell lines from Aedes albopictus and Aedes aegypti. Curr. Sci. 37, 65–67 (1968).
Cited by
Items 801–900 of 1,001
Challenges for the formulation of a universal vaccine against dengue
Chokephaibulkit, K., & Perng, G. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370212473703 · Cited by 22
Cheng, H., Luo, Y.-H., Wan, S.-W., Lin, C., Wang, S., Hùng, N. T., Liu, C., Ho, T., Liu, H., Yeh, T., et al. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0162 · Cited by 22
Dengue Chikungunya co-infection: A live-in relationship??
Jain, J., Dubey, S., Shrinet, J., & Sunil, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.008 · Cited by 22
Peridomestic Aedes malayensis and Aedes albopictus are capable vectors of arboviruses in cities
Mendenhall, I. H., Manuel, M., Moorthy, M., Lee, T. T. M., Low, D. H. W., Missé, D., Gubler, D. J., Ellis, B. R., Ooi, E. E., & Pompon, J. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005667 · Cited by 22
“dengue and chikungunya outbreaks, especially in large cities, [1, 15, 16] have raised concerns about the sustainability of the current approach targeting domestic vectors [1, 16, 17].”
BackgroundSelf-citationOne-step multiplex real-time RT-PCR for detection and typing of dengue virus
Mun, M.-J., Bae, J., Kim, J. H., Kim, S. B., Lee, I., Kim, J. I., Park, M. S., Park, M., & Nam, Y. S. (2018) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2018.10.001 · Cited by 22
Insecticide resistance in Aedes albopictus Skuse from sub-Himalayan districts of West Bengal, India
Bharati, M., Rai, P., & Saha, D. (2019) · Acta Tropica · doi:10.1016/j.actatropica.2019.02.007 · Cited by 25
Dengue virus and other arboviruses: a global view of risks
Áñez, G., Chancey, C., Grinev, A., & Rios, M. (2012) · ISBT Science Series · doi:10.1111/j.1751-2824.2012.01602.x · Cited by 22
Cardoso, S. A., Paixão, V. F., de Oliveira, M. D., Honda, E. R., de Oliveira, L. L., da Silva, C. C., & de Paula, S. O. (2013) · Protein Expression and Purification · doi:10.1016/j.pep.2013.08.014 · Cited by 22
The Low-Density Lipoprotein Receptor-Related Protein-1 Is Essential for Dengue Virus Infection
Huerta, V., Martin, A. M., Sarría, M., Guirola, O., Yero, A., Ramos, Y., Gómez, D. P., Martín, D., Carletti, T., González‐Lodeiro, L. G., et al. (2024) · Viruses · doi:10.3390/v16111692 · Cited by 22
Brivanib alaninate inhibited dengue virus proliferation through VEGFR2/AMPK pathway
Wan, Y., Wu, W., Wan, Y., Li, L., Zhang, J., Chen, X., Liu, S., & Yao, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105721 · Cited by 21
Immunological and Pathological Landscape of Dengue Serotypes 1-4 Infections in Immune-Competent Mice
Rathore, A. P. S., Mantri, C. K., Tan, M. W., Shirazi, R., Nishida, A., Aman, S. A. B., Morrison, J. M., & John, A. L. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.681950 · Cited by 21
Molecular Characterization of Imported and Autochthonous Dengue in Northeastern Spain
Navero‐Castillejos, J., Benitez, R., Torner, N., Muñóz, J., Camprubí-Ferrer, D., Peiró-Mestres, A., Sulleiro, E., Silgado, A., Gonzalo, V., Falgueras, T., et al. (2021) · Viruses · doi:10.3390/v13101910 · Cited by 23
“Diagnosis is based on viral detection assays, mainly reverse transcription polymerase chain reaction (RT-PCR) and non-structural 1 (NS1) antigen detection assays during the acute viremic phase and serological tests for detection of IgM and IgG against DENV, which may show cross-reactions with antibodies against other…”
MethodThe Dengue virus protease NS2B3 cleaves cyclic GMP-AMP synthase to suppress cGAS activation
Bhattacharya, M., Bhowmik, D., Tian, Y., He, H., Zhu, F., & Yin, Q. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102986 · Cited by 21
“(2023) 299(3) 102986 and D157, essentially separating the N-terminal region from the C-terminal catalytic domain (26).”
BackgroundMethodResultInfluentialBoonyasuppayakorn, S., Saelee, T., Huynh, T. N. T., Hairani, R., Hengphasatporn, K., Loeanurit, N., Cao, V., Vibulakhaophan, V., Siripitakpong, P., Kaur, P., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-32049-x · Cited by 21
Dengue Fever: Etiology, Diagnosis, Prevention and Treatment
Nyenke, C. U., Nnokam, B. A., Esiere, R. K., & Nwalozie, R. (2023) · Asian Journal of Research in Infectious Diseases · doi:10.9734/ajrid/2023/v14i1279 · Cited by 21
“In the initial phases of the illness, all testing might come back negative [18].”
Background(2013) · PubMed Central · Cited by 25
Tozan, Y., Ratanawong, P., Louis, V. R., Kittayapong, P., & Wilder‐Smith, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108017 · Cited by 22
“Among symptomatic cases, disease severity varies from mild, self-limiting febrile illness to severe to fatal hemorrhagic disease–the latter more commonly experienced by children and adolescences under the age of fifteen [2,3].”
BackgroundViral Immune Evasion in Dengue: Toward Evidence-Based Revisions of Clinical Practice Guidelines
Chiappelli, F., Santos, S. M. E., Brant, X., Bakhordarian, A., Thames, A. D., Maida, C. A., Du, A. M., Jan, A. L., Nahcivan, M., Nguyen, M. T., et al. (2014) · Bioinformation · doi:10.6026/97320630010726 · Cited by 21
Resequencing microarray method for molecular diagnosis of human arboviral diseases
Berthet, N., Paulous, S., Coffey, L. L., Frenkiel, M., Moltini-Conclois, I., Tran, C., Matheus, S., Ottone, C., Ungeheuer, M., Renaudat, C., et al. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.10.022 · Cited by 21
Computational analysis reveal inhibitory action of nimbin against dengue viral envelope protein
Lavanya, P., Ramaiah, S., & Anbarasu, A. (2015) · VirusDisease · doi:10.1007/s13337-015-0280-x · Cited by 21
The non-canonical Notch signaling is essential for the control of fertility in Aedes aegypti
Chang, C.-H., Liu, Y., Weng, S., Chen, I.-Y., Tsao, P., & Shiao, S.-H. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006307 · Cited by 21
Viral immunogenicity determines epidemiological fitness in a cohort of DENV-1 infection in Brazil
Pinheiro, T. M., Mota, M. T. D. O., Watanabe, A. S. A., Biselli, J. M., Drumond, B. P., Ribeiro, M. R., Vedovello, D., Araújo, J. P., Pimenta, P. F. P., Chaves, B. A., et al. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006525 · Cited by 21
Kayesh, M. E. H., Kohara, M., & Tsukiyama–Kohara, K. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.744233 · Cited by 25
“The first dengue vaccine, chimeric yellow fever 17D-tetravalent dengue vaccine (CYD-TDV)/Dengvaxia, was developed by Sanofi Pasteur Co., and licensed in 2015 (Hadinegoro et al., 2015).”
BackgroundQian, W., Xue, J.-X., Xu, J., Li, F., Zhou, G., Wang, F., Luo, R., Liu, J., Zheng, Y., & Zhou, G. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105639 · Cited by 21
TERAMOTO, T., Boonyasuppayakorn, S., Handley, M. D., Choi, K. H., & Padmanabhan, R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.584466 · Cited by 21
“Four serotypes of dengue virus (D1–D4(2)) are endemic or epidemic in 100 countries in tropical and subtropical regions of the world (1).”
BackgroundPadilla-Torres, S. D., Ferraz, G., Luz, S. L. B., Zamora-Perea, E., & Abad‐Franch, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058420 · Cited by 25
“About 50 million people contract dengue annually, and an estimated 22,000 die from severe forms of the disease [3,4].”
BackgroundKlungthong, C., Manasatienkij, W., Phonpakobsin, T., Chinnawirotpisan, P., Rodpradit, P., Hussem, K., Thaisomboonsuk, B., Ong-ajchaowlerd, P., Nisalak, A., Kalayanarooj, S., et al. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.12.009 · Cited by 21
Roldán, S. C. A., Santacoloma, L., & Brochero, H. L. M. (2013) · Biomédica · doi:10.7705/biomedica.v33i3.1534 · Cited by 21
“La incidencia de esta virosis se ha incrementado en el mundo desde la década de 1950 (1), estimándose que se infectan entre 50 y 100 millones de personas con el virus del dengue cada año (2).”
BackgroundFreire, J. M., Veiga, A. S., de la Torre, B. G., Santos, N. C., Andreu, D., Poian, A. T. D., & Castanho, M. A. R. B. (2013) · Biopolymers · doi:10.1002/bip.22266 · Cited by 21
Bharati, M., & Saha, D. (2017) · Acta Tropica · doi:10.1016/j.actatropica.2017.02.029 · Cited by 23
Susceptibility of LarvalAedes aegyptiandAedes albopictus(Diptera: Culicidae) to Dengue Virus
Bara, J. J., Clark, T. M., & Remold, S. K. (2013) · Journal of Medical Entomology · doi:10.1603/me12140 · Cited by 21
Probability of consolidation constrains novel serotype emergence in dengue fever virus
Sánchez‐González, G., Belak, Z. R., Lozano, L., & Condé, R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248765 · Cited by 20
Dahora, L. C., Castillo, I. N., Medina, F. A., Vila, F., Segovia-Chumbez, B., Muñoz‐Jordán, J. L., Whitehead, S. S., Adams, L. E., Paz‐Bailey, G., de Silva, A. M., et al. (2024) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.07.014 · Cited by 20
Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice
Chiang, C.-Y., Liu, S., Hsieh, C.-H., Chen, M., Tsai, J.-P., Liu, H., Chen, I.-H., Chong, P. C.-S., Leng, C., & Chen, H. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.01.009 · Cited by 21
Potential of Aedes aegypti populations in Madeira Island to transmit dengue and chikungunya viruses
Seixas, G., Jupille, H., Yen, P., Viveiros, B., Failloux, A., & Sousa, C. A. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-3081-4 · Cited by 20
T-Cell mediated adaptive immunity and antibody-dependent enhancement in secondary dengue infection
Sasmal, S. K., Takeuchi, Y., & Nakaoka, S. (2019) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2019.03.010 · Cited by 20
Islam, R., Parvez, M. S. A., Anwar, S., & Hosen, M. J. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100430 · Cited by 22
Sinha, M., Chakraborty, U., Kool, A., Chakravarti, M., Das, S., Ghosh, S., Thakur, L., Khurana, A., Nayak, D., Basu, B., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114627 · Cited by 20
Role of Lectin in the Response of Aedes aegypti Against Bt Toxin
Alam, I., Batool, K., Idris, A. L., Tan, W., Guan, X., & Zhang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.898198 · Cited by 22
“Dengue viruses (DENVs) are the causal agents of dengue fever, a viral infectious mosquito-borne disease that spreads across the world’s tropics and subtropics (92).”
BackgroundSu, W., Jiang, L., Lu, W., Xie, H., Cao, Y., Di, B., Li, Y., Nie, K., Wang, H., Zhang, Z., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01210-22 · Cited by 28
Cepharanthine inhibits dengue virus production and cytokine secretion
Phumesin, P., Panaampon, J., Kariya, R., Limjindaporn, T., Yenchitsomanus, P., & Okada, S. (2022) · Virus Research · doi:10.1016/j.virusres.2022.199030 · Cited by 20
“Annually, approximately 390 million people are at risk for dengue virus (DENV) infection, including 500,000 dengue hemorrhagic fever (DHF) cases and 22,000 deaths, mostly children (Guzman et al., 2010; Organization., 2011).”
BackgroundSinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity
Shukla, R., Ahuja, R., Beesetti, H., Garg, A., Aggarwal, C., Chaturvedi, S., Nayyar, K., Arora, U., Lal, A. A., & Khanna, N. (2023) · Scientific Reports · doi:10.1038/s41598-023-27927-3 · Cited by 20
Sreekanth, G. P. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115416 · Cited by 21
Escudero-Flórez, M., Torres-Hoyos, D., Miranda-Brand, Y., Boudreau, R. L., Gallego-Gómez, J. C., & Vicente‐Manzanares, M. (2023) · Viruses · doi:10.3390/v15071437 · Cited by 24
Bautista, P. F. H., Cabrera-Gaytán, D. A., Santacruz-Tinoco, C. E., Vallejos-Parás, A., Alvarado-Yaah, J. E., Martínez-Miguel, B., Hernández, Y. M. A., Nieto, L. A., Moctezuma-Paz, A., Betancourt, L. J., et al. (2024) · Viruses · doi:10.3390/v16050769 · Cited by 30
“In 2023, dengue reached a historical peak with over five million cases and more than 5000 deaths globally, with approximately 80% of cases reported in the Americas region [4,5].”
BackgroundCoelho, F. C., & Carvalho, L. M. (2015) · Scientific Reports · doi:10.1038/srep18455 · Cited by 20
“Dengue is an arthropod-borne febrile disease caused by a flavivirus with four serotypes which causes an estimated 50 million infections each year [1].”
Lee, J., Kim, H. Y., Chong, C., & Song, H. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.03.009 · Cited by 20
“All the samples were tested by RT-PCR (Waggoner et al., 2013) to confirm DENV infection and to determine the serotype of DENV.”
MethodHuman monoclonal single-chain antibodies specific to dengue virus envelope protein
Saokaew, N., Poungpair, O., Panya, A., Tarasuk, M., Sawasdee, N., Limjindaporn, T., Chaicumpa, W., & Yenchitsomanus, P. (2013) · Letters in Applied Microbiology · doi:10.1111/lam.12186 · Cited by 20
“More than one-third of the world population is living in endemic areas, and 100 million people are infected yearly (Guzman et al. 2010).”
BackgroundKim, J.-H., Chong, C., Sinniah, M., Sinnadurai, J., Song, H., & Park, H. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.01.018 · Cited by 20
“These heterotypic infections can cause clinical manifestations such as dengue hemorrhagic fever and dengue shock syndrome [4,7,9–11].”
BackgroundPieprzyk, J., Zbela, A., Jakób, M., Ożyhar, A., & Orłowski, M. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.03.010 · Cited by 20
Lee, J., Kim, Y., Kim, H. Y., Sinniah, M., Chong, C., & Song, H. (2015) · Scientific Reports · doi:10.1038/srep18077 · Cited by 20
Vongsouvath, M., Phommasone, K., Sengvilaipaseuth, O., Kosoltanapiwat, N., Chantratita, N., Blacksell, S. D., Lee, S. J., de Lamballerie, X. N., Mayxay, M., Keomany, S., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004704 · Cited by 20
“The dengue virus (DENV) is an enveloped ssRNA flavivirus transmitted by Aedesmosquitoes [1].”
BackgroundOptical diagnosis of dengue virus infected human blood using Mueller matrix polarimetry
Anwar, S., & Firdous, S. (2016) · Optics and Spectroscopy · doi:10.1134/s0030400x16080208 · Cited by 20
Growing water insecurity and dengue burden in the Americas
Akanda, A. S., & Johnson, K. (2018) · The Lancet Planetary Health · doi:10.1016/s2542-5196(18)30063-9 · Cited by 20
Larval density mediates knockdown resistance to pyrethroid insecticides in adult Aedes aegypti
Grossman, M. K., Uc-Puc, V., Flores, A. E., Manrique-Saide, P. C., & Vazquez‐Prokopec, G. M. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-2865-x · Cited by 21
“throughout the world employ ultra-low volume spraying (ULV), indoor residual spraying (IRS), and the application of larvicides to target individuals in both the aquatic and terrestrial life stages [8, 9].”
BackgroundOtu, A. A., Udoh, U. A., Ita, O. I., Hicks, J. P., Egbe, W., & Walley, J. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215143 · Cited by 26
Tsai, C.-L., Sun, D., Su, M.-T., Lien, T.-S., Chen, Y., Lin, C.-Y., Huang, C., King, C., Li, C.-R., Chen, T.-H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62958-0 · Cited by 20
Eldigail, M. H., Abubaker, H. A., Khalid, F. A., Abdallah, T. M., Adam, I. A., Adam, G. K., Babiker, R. A., Ahmed, M. E., Haroun, E. M., & Aradaib, I. E. (2020) · BMC Public Health · doi:10.1186/s12889-020-08656-y · Cited by 20
Azami, N. A. M., Moi, M. L., Salleh, S. A., Neoh, H., Kamaruddin, M. A., Jalal, N. A., Ismail, N., Takasaki, T., Kurane, I., & Jamal, R. (2020) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/traa056 · Cited by 24
Decker, S. D., Vray, M., Sistek, V., Labeau, B., Enfissi, A., Rousset, D., & Matheus, S. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003596 · Cited by 20
“accuracy of this test evaluated under our criteria could provide better diagnostic value if combined with another direct diagnostic test, as commonly illustrated and recommended [1,4,6,7,25,26].”
MethodChang, K., Chen, C.-D., Shih, C.-M., Lee, T.-C., Wu, M., Wu, D., Chen, Y., Hung, C., Wu, M.-C., Huang, C.-C., et al. (2016) · Scientific Reports · doi:10.1038/srep35028 · Cited by 20
“The potential mechanisms of transmission in the current case are as follows: (1) the gutters were destroyed in the blast area, and dengue vector mosquitos living beneath the street flew out to damaged houses, potholes, and other habitats; (2) the disaster zone was blocked, thus epidemic prevention programs for dengue…”
ResultEndoplasmic reticulum in viral infection
Bagchi, P. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.10.005 · Cited by 22
The inability of a dengue NS1 ELISA to detect Zika infections
Lima, M. D. R. Q., Chouin-Carneiro, T., de Azeredo, E. L., Barbosa, L. S., de Souza, T. M. A., da Silva, J. B. C., Nunes, P. C. G., Fabbro, M. D., Romanholi, I. H., da Cunha, R. V., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55160-4 · Cited by 19
Sirivichayakul, C., Barranco-Santana, E. A., Esquilin, I. O., Kilbury, J., Raanan, M. G., Borkowski, A., Papadimitriou, A., & Wallace, D. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa406 · Cited by 19
“It has been estimated that worldwide 390 million dengue infections occur annually, of which 96 million are symptomatic [6], and 500 000 cases require hospitalization [7].”
BackgroundPiedimonte, P., Solá, L., Cretich, M., Gori, A., Chiari, M., Marchisio, E., Borga, P., Bertacco, R., Melloni, A. I., Ferrari, G., et al. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.113996 · Cited by 19
Mohanty, L., Prabhu, M., Mishra, A. K., Purty, A. J., Kanungo, R., Ghosh, G., Kumar, R. P., Raj, A. N., Bhushan, S., Jangir, M. K., et al. (2022) · Vaccine X · doi:10.1016/j.jvacx.2022.100142 · Cited by 19
Preparedness for the Dengue Epidemic: Vaccine as a Viable Approach
Zeyaullah, M., Muzammil, K., AlShahrani, A. M., Khan, N., Ahmad, I. S., Alam, M. S., Ahmad, R., & Khan, W. H. (2022) · Vaccines · doi:10.3390/vaccines10111940 · Cited by 19
“However, some DF patients develop an astringent syndrome known as the Dengue hemorrhagic fever (DHF), in which patients may exhibit hematomas with marked thrombocytopenia or astronomically low platelet counts [15].”
BackgroundDiagnosing arthropod-borne flaviviruses: non-structural protein 1 (NS1) as a biomarker
Ceconi, M., Ariën, K. K., & Delputte, P. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.11.016 · Cited by 19
Dengue Vaccine Development: Strategies and Challenges
Ramakrishnan, L., Pillai, M. R., & Nair, R. R. (2014) · Viral Immunology · doi:10.1089/vim.2014.0093 · Cited by 19
“The envelope is a lipid bilayer studded with two structural proteins—envelope (E) and membrane (M)—which have roles in host cell entry and virus maturation, respectively (39).”
Shen, W., & Gao, Z. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.10.060 · Cited by 20
Kovendan, K., Shanthakumar, S. P., Cheruparambath, P., Kumar, P. M., Murugan, K., & Vincent, S. (2014) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(14)60435-7 · Cited by 19
Dengue Vaccines: Challenge and Confrontation
Perng, G., Lei, H., Lin, Y., & Chokephaibulkit, K. (2011) · World Journal of Vaccines · doi:10.4236/wjv.2011.14012 · Cited by 22
“Furthermore, the assays currently available to measure neutralizing antibodies are not suitable to identify the true protective homotypic antibody and cannot differentiate between type specific, heterotypic and cross-reactive antibodies [44,64,191,192].”
BackgroundMitra, S., Choudhari, R., Nori, H., Abhilash, K. P. P., Jayaseelan, V., Abraham, A. M., Cherian, A., Prakash, J. A. J., & Muliyil, J. (2016) · Journal of Vector Borne Diseases · doi:10.4103/0972-9062.179216 · Cited by 19
“(1) Malaria: Negative peripheral blood smear for malarial parasites.”
BackgroundInfluentialA NEW COPPER (II)-IMIDAZOLE DERIVATIVE EFFECTIVELY INHIBITS REPLICATION OF DENV-2 IN VERO CELL
Sucipto, T. H., Churrotin, S., Setyawati, H., Martak, F., Mulyatno, K. C., Amarullah, I. H., Kotaki, T., Kameoka, M., Yotopranoto, S., & Soegijanto, S. (2018) · African Journal of Infectious Diseases · doi:10.21010/ajid.v12i1s.17 · Cited by 19
Maternal Passive Immunity and Dengue Hemorrhagic Fever in Infants
Adimy, M., Mancera, P. F. D. A., Rodrigues, D. S., dos Santos, F. L. P., & Ferreira, C. P. (2020) · Bulletin of Mathematical Biology · doi:10.1007/s11538-020-00699-x · Cited by 22
Ahmad, W., Lubna, Z., Aijaz, M., & Afroz, N. (2020) · Archives of Hematology Case Reports and Reviews · doi:10.17352/ahcrr.000021 · Cited by 19
“A second infection with a different serotype leads to more severe form of the disease than the primary infection [3].”
BackgroundDenvInD: dengue virus inhibitors database for clinical and molecular research
Dwivedi, V. D., Arya, A., Yadav, P., Kumar, R., Kumar, V. D., & Raghava, G. P. S. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa098 · Cited by 19
(2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812365-2.00003-2 · Cited by 25
Apoptotic mediators in patients with severe and non‐severe dengue from Brazil
Limonta, D., Torrentes‐Carvalho, A., Marinho, C. F., de Azeredo, E. L., de Souza, L. J., Motta-Castro, A. R. C., da Cunha, R. V., Kubelka, C. F., Nogueira, R. M. R., & de‐Oliveira‐Pinto, L. M. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23832 · Cited by 20
“C 2013 WILEY PERIODICALS, INC. Organization, 2009; Guzman et al., 2010; Simmons et al., 2012].”
BackgroundMyocarditis Leading to Severe Dilated Cardiomyopathy in a Patient with Dengue Fever
Tahir, H., Daruwalla, V., & Hayat, S. (2015) · Case Reports in Cardiology · doi:10.1155/2015/319312 · Cited by 19
“It is speculated that antibody dependent enhancement (ADE) is the mechanism responsible for severe disease in secondary infection [11, 12].”
BackgroundWilder‐Smith, A., Byass, P., Olanratmanee, P., Maskhao, P., Sringernyuang, L., Logan, J. G., Lindsay, S. W., Banks, S., Gubler, D. J., Louis, V. R., et al. (2012) · Trials · doi:10.1186/1745-6215-13-212 · Cited by 19
“Children carry the main burden of morbidity and mortality for dengue with a higher rate of complications, including DHF and shock syndromes, than in adults [6].”
BackgroundSelf-citationZuharah, W. F., Ahbirami, R., Dieng, H., Thiagaletchumi, M., & Fadzly, N. (2016) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946201658044 · Cited by 19
Dengue hospitalisations in Brazil: annual wave from West to East and recent increase among children
Wunderlich, J., Acuña-Soto, R., & Alonso, W. J. (2017) · Epidemiology and Infection · doi:10.1017/s0950268817002801 · Cited by 19
“Moreover, the emergence of Zika virus (ZIKV) in the Americas in 2015, and its rapid spread in 2016, renewed the interest in dengue virus, given their phylogenetic proximity and shared mosquito vector species: Aedes aegypti and Aedes albopictus, also known as the yellow fever mosquito and Asian tiger mosquito, respecti…”
BackgroundInfluentialMalhi, N. S. (2017) · Journal of Liver Research Disorders & Therapy · doi:10.15406/jlrdt.2017.03.00063 · Cited by 19
“These factors include poor hygiene, broken health system and booming international travels [1,2].”
BackgroundLucidone suppresses dengue viral replication through the induction of heme oxygenase-1
Chen, W., Tseng, C.-K., Lin, C., Wang, S., Wang, W., Hsu, S., Wu, Y., Hung, L.-C., Chen, Y., & Lee, J. (2018) · Virulence · doi:10.1080/21505594.2017.1421893 · Cited by 20
Huerta, V., Ramos, Y., Yero, A., Pupo, D., Martín, D., Toledo, P., Fleitas‐Salazar, N., Gallien, S., Martin, A. M., Márquez, G., et al. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.11.003 · Cited by 19
Li, M., Xu, Y., Li, K., Chao Hui, Z. H. O. U., Fan, X.-X., Wang, H., Shi, P., Li, R.-T., Wang, Z.-X., Cao, T.-S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63323-3 · Cited by 22
“DENV infection in humans affects various organ systems, with viral nucleic acids and antigens detected in multiple tissues 7 – 9 .”
Current emerging situation of dengue in India
Mariappan, T. (2013) · Tropical Doctor · doi:10.1177/0049475513491944 · Cited by 18
“Although epidemics of DF were first reported from Africa, and later from Malaysia in the 19th century, it has since been recorded in more than 120 countries.(5) The earliest virologically confirmed outbreak occurred in 1956 in Vellore, Tamil Nadu, followed by a large epidemic in 1963 in Calcutta, West Bengal, and majo…”
BackgroundDengue: An Analysis of Epidemiological Pattern Over a Six Year Period
Singla, N. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/22482.9011 · Cited by 18
Rathore, M. H., Runyon, J., & Haque, T.-U. (2017) · Advances in Pediatrics · doi:10.1016/j.yapd.2017.04.002 · Cited by 18
Species-specific climate Suitable Conditions Index and dengue transmission in Guangdong, China
Lu, X., Bambrick, H., Frentiu, F. D., Huang, X., Davis, C., Li, Z., Yang, W., Devine, G. J., & Hu, W. (2022) · Parasites & Vectors · doi:10.1186/s13071-022-05453-x · Cited by 21
“albopictus, once zoophilic forest species from sub-Saharan Africa and Asia, respectively, are now widespread globally due to the rapid growth of the human population, intensified international travel in the last century and, more recently, climate change [6, 7].”
BackgroundEpidemiological Characteristics and Economic Burden of Dengue in Zhejiang Province, China
Yu, Y., Liu, Y., Feng, L., Sun, J., & Jiang, J. (2023) · Viruses · doi:10.3390/v15081731 · Cited by 21
Dengue fever: a decade of burden in Iran
Heydarifard, Z., Heydarifard, F., Mousavi, F., & Zandi, M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1484594 · Cited by 21
“(Stegomyia) albopictus mosquitoes, DENV shares its vectors with other notable viruses such as chikungunya (CHIKV), Zika (ZIKV), and yellow fever (2).”
BackgroundRT‐RPA Assisted CRISPR/Cas12a Based One‐Pot Rapid and Visual Detection of the Pan‐Dengue Virus
Bhardwaj, P., Dhangur, P., Alagarasu, K., & Singh, R. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70219 · Cited by 18
High Mobility Group Box 1 Protein as an Auxiliary Biomarker for Dengue Diagnosis
Allonso, D., Vázquez, S., Guzmán, M. G., & Mohana‐Borges, R. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0619 · Cited by 18
“Severe cases of dengue are responsible for more than 500,000 hospitalizations and thousands of deaths, which occur principally in children.(1)”
Challenges in reducing dengue burden; diagnostics, control measures and vaccines
Lam, S. K. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.824712 · Cited by 18
Developing a Social Autopsy Tool for Dengue Mortality: A Pilot Study
Arauz, M. J., Ridde, V., Hernández, L. M., Charris, Y., Carabalí, M., & Villar, L. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117455 · Cited by 18
Dias, A., de Nonohay, U., & Blessmann, G. (2012) · Arquivos rio-grandenses de medicina · Cited by 18
Goldhardt, R., Patel, H., & Davis, J. L. (2016) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2015.1125513 · Cited by 18
“Dengue fever is of increasing international concern as a result of growing urbanization, tourism, and trade.(1) It is one of the most rapidly spreading vector-borne diseases in the world, with the incidence increasing 30-fold in the past 50 years, with 2.”
BackgroundTaylor-Robinson, A. W., & Subedi, D. (2016) · Journal of Vector Borne Diseases · doi:10.4103/0972-9062.179208 · Cited by 18
Metadata
- Authors
- Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., Nathan, M. B., Pelegrino, J. L., Simmons, C., Yoksan, S., & Peeling, R. W.
- Affiliations
- Public Health Agency of Canada (CA)
- Institut Pasteur du Cambodge (KH)
- Oxford University Clinical Research Unit (VN)
- National University of Singapore (SG)
- Centers for Disease Control and Prevention (US)
- World Bank (US)
- Instituto de Medicina Tropical “Pedro Kourí” (CU)
- World Health Organization (CH)
- Mahidol University (TH)
- Corresponding author
- Peeling, Rosanna W.
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2010-12
- Volume
- 8
- Issue
- S12
- Pages
- S7-S16
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC4333201
- OpenAlex
- W2042479028
- Cited by
- 2,082
- References
- 130
- Citations by year
- 2026: 68 · 2025: 104 · 2024: 94 · 2023: 135 · 2022: 116 · 2021: 133 · 2020: 140 · 2019: 127 · 2018: 142 · 2017: 151 · 2016: 163 · 2015: 189 · 2014: 186 · 2013: 161 · 2012: 132
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Wellcome Trust (084368)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Dengue and Mosquito Control Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Keywords
- dengue, dengue hemorrhagic fever, arboviruses, dengue serotypes, vector-borne diseases, dengue surveillance, outbreak response, integrated vector management, early diagnosis, dengue vaccine, antiviral agents, dengue control
- MeSH terms
- Americas, Asia, Southeastern, Dengue, Dengue Virus, Hospitalization, Humans, Insect Control, Pacific Islands
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.